Fulminant sepsis related to Vibrio vulnificus. Series of cases;Sepsis fulminante por Vibrio vulnificus. Serie de casos

Revista de Investigacion Clinica

Volumn 52, Issue 6, 2000, Pages 632-637

  Cornejo Juárez, Patricia ^a   De Oca, Ana Lilia Rolón Montes ^a   Tinoco Favila, Juan Carlos ^a,b   Sifuentes Osornio, José ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Hospital General de Durango   (Mexico)

Author keywords

Chronic hepatic disease; Hemorrhagic bullaes; Raw shellfish; Septicemia; Vibrio vulnificus

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; TETRACYCLINE; TIMENTIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MALE; MORTALITY; RISK FACTOR; SEPSIS; VIBRIO VULNIFICUS;

FEMALE; HUMANS; MALE; MIDDLE AGED; SEPSIS; VIBRIO INFECTIONS;

EID: 1642450021     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hlady G, Klontz K. The epidemiology of vibrio infections in Florida, 1981-1993. J Infect Dis 1996; 173: 1176-83.
2. Porras G, Viana J, Chávez B, Sierra J. Vibrio vulniflcus en México: reporte de un caso y revisión de la literatura. Rev Invest Clin 1994; 46: 495-8.
3. Eastaugh J, Shepherd S. Infectious and toxic syndromes from fish shellfish consumption. Arch Intern Med 1989; 149: 1735-40.
4. Mascola L, Tormey M, Dassey D et al. Vibrio vulnificus infections associated with eating raw oysters - Los Angeles, 1996. JAMA 1996; 276: 937-8.
5. Wongpaitoon V, Sathapatayavongs B, Prachaktam R, Bunyaratvej S, Kurathong S. Spontaneous Vibrio vulnificus peritonitis and primary sepsis in two patients with alcoholic cirrhosis. Am J Gastroent 1985; 80: 706-8.
6. Tacket C, Brenner F, Blake P. Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 1984; 149: 558-61.
7. Chuang Y, Yuan C, Liu C, Lan C, Hwei-Mei A. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 1992; 15: 271-6.
8. Ko W, Chuang Y, Huang G, Hsu S. Infections due to non-01 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients. Clin Infect Dis 1998; 27: 774-80.
9. Morris G, Black R. Cholera and other vibrioses in the United States. N Eng J Med 1985; 312: 343-50.
10. Levine WC, Griffin PM. The Gulf Coast Vibrio Working Group. Vibrio infections on the gulf coast: results of the first year of regional surveillance. J Infect Dis 1993; 167: 479-83.
11. Chuang Y, Ko W, Wang S et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 1998; 42: 1319-22.
12. Johnston J, Andes A, Glasser G. Vibrio vulnificus. A gastronomic hazard. JAMA 1983; 249: 1756-7.
13. Blake P, Merson M, Weaver R, Hollis D, Heublein P. Disease caused by a marine vibrio. Clinical characteristics and epidemiology. N Eng J Med 1979; 300: 1-5.
14. Klontz K, Lieb S, Schreiber M et al. Syndromes of Vibrio vulnificus infections. Ann Intern Med 1988; 109: 318-23.
15. Hoffmann T, Nelson B, Darouiche R, Rosen T. Vibrio vulnificus septicemia. Arch Intern Med 1988; 148: 1825-7.
16. Johnston J, Becker S, McFarland L. Vibrio vulnificus. Man and the sea. JAMA 1985; 253: 2850-3.
17. Hor L, Chang T, Wang S. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 1999; 179: 275-8.
18. Tyring S, Lee P. Hemorrhagic bullae associated with Vibrio vulnificus septicemia. Arch Dermatol 1986; 122: 818-20.
19. Muench K. Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med 1989; 87: (3N) 40-43.
20. Chin K, Lowe M, Tong M, Koehler A. Vibrio vulnificus infection after raw oyster ingestion in a patient with liver disease and acquired immune deficiency syndrome-related complex. Gastroenterology 1987; 92: 796-9.
21. Hoge C, Watsky D, Peeler R, Libonati J, Israel E, Morris G. Epidemiology and spectrum of vibrio infections in a Chesapeake Bay community. J Infect Dis 1989: 160: 985-93.
22. Anonymous. From the NIH. Highly invasive new bacterium isolated from US east coast waters. JAMA 1984; 251: 323-5.
23. Bonner J, Coker A, Berryman C, Pollock H. Spectrum of vibrio infections in a gulf coast community. Ann Intern Med 1983; 99: 464-9.
24. Chuang Y, Liu J, Ko W, Lin K, Wu J, Huang K. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother 1997; 41: 2214-7.
25. Morris J, Tenney J. Antibiotic therapy for Vibrio vulnificus infection. JAMA 1985; 253: 1121-2.
26. Fang F. Use of tetracycline for treatment of Vibrio vulnificus infections. Clin Infect Dis 1992; 15: 1071-2.